Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Veradigm Inc. - common stock (OP: MDRX )

4.400 UNCHANGED
Streaming Delayed Price Updated: 9:33 AM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 151
Open 4.400
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 4.400
Today's Range 4.400 - 4.400
52wk Range 3.800 - 11.80
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Black Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solution Vendor in 2025
From Veradigm
Via Business Wire
Syracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational Efficiency
From Veradigm
Via Business Wire

Performance

YTD
-51.65%
-51.65%
1 Month
+5.01%
+5.01%
3 Month
-43.23%
-43.23%
6 Month
-51.11%
-51.11%
1 Year
-45.21%
-45.21%

More News

Read More
Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership
From Veradigm Inc.
Via Business Wire
Veradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025
From Veradigm
Via Business Wire
Veradigm Files Fiscal 2022 Form 10-K and Restated Financial Statements
From Veradigm
Via Business Wire
Veradigm to Release Financial Update March 18th and Host Investor Call March 19th
From Veradigm
Via Business Wire
Over 3,500 Healthcare Practices Receive Gaps-in-Care Alerts at the Point-of-Care via Veradigm Payer Insights Solution
From Veradigm
Via Business Wire
Veradigm Becomes First EHR Media Platform to Achieve POCMA Certification
From Veradigm
Via Business Wire
Veradigm Announces Board Expansion and Changes
From Veradigm
Via Business Wire
Veradigm Amends and Extends Stockholder Rights Plan
From Veradigm
Via Business Wire
Veradigm Introduces Cardiometabolic Clinical Registry Datasets to Enhance the Next Generation of Real-World Research
From Veradigm
Via Business Wire
Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices
From Veradigm
Via Business Wire
Veradigm Concludes Exploration of Strategic Alternatives and Announces Operational Review
From Veradigm
Via Business Wire
Veradigm Announces the Resignation of Board Director Beth Altman Due to Health Reasons
From Veradigm
Via Business Wire
Veradigm Adds Social Determinants of Health and Mortality Data to EHR Database to Allow Deeper Insights into the Patient Journey
From Veradigm
Via Business Wire
Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
From Glancy Prongay & Murray LLP
Via Business Wire
Veradigm Launches an Ambient Scribe Advancement to Ease the Healthcare Administrative Burden
From Veradigm
Via Business Wire
Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration
From Veradigm
Via Business Wire
Veradigm Advances Deeper Clinical Insights Through NLP-Enhanced EHR Data
From Veradigm
Via Business Wire
Automated Medical Chart Retrieval Expands to 300,000+ U.S. Healthcare Providers via Veradigm eChart Courier
From Veradigm
Via Business Wire
Veradigm Ranked Top Vendor by KLAS
From Veradigm
Via Business Wire
Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions
From Veradigm
Via Business Wire
Positive Impact Observed at Many Orthopedic Practices Utilizing Veradigm Coding Services
From Veradigm
Via Business Wire
Black Book ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solutions Vendor in 2024
From Veradigm
Via Business Wire
Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
From Robbins LLP
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.